Sign In
Buy GRFS
$7.18
-0.100 (-1.37%)
At Close: Jun 23, 2026
Did Hedge Funds Make The Right Call On Grifols SA (GRFS) ?
04:45pm, Friday, 17'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Biomarin's Hemophilia A Drug Among 5 Up for FDA Approval Soon
07:57pm, Thursday, 09'th Jul 2020
If approved, company’s Roctavian would become first gene therapy for inherited disease Continue reading...
Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe
12:19pm, Thursday, 09'th Jul 2020
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Grifols S.A., its collaborative partner in Europe, has launched TAVLESSE® in Germany and the United Kingdom. It was approved by the Eur
5 Health Care Stocks Boosting Earnings
03:18pm, Tuesday, 30'th Jun 2020
Biogen tops the list Continue reading...
MORNING BID-Counteracting forces
08:22am, Wednesday, 24'th Jun 2020
A strong performance today from trade-exposed Korean stocks and currency. U.S. Treasury Secretary Steven Mnuchin said he may further delay tax-filing deadlines and White House adviser Larry Kudlow sa
Hedge Funds Never Loved Grifols SA (GRFS) More
03:12pm, Thursday, 18'th Jun 2020
In this article we will take a look at whether hedge funds think Grifols SA (NASDAQ:GRFS) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hou
5 Undervalued Companies With Profitable Business
03:54pm, Friday, 12'th Jun 2020
Comcast makes the list Continue reading...
The Daily Biotech Pulse: Sorrento Submits EUA Application For Rapid Coronavirus Test, Decision Day For Viela, Lantern Pharma IPO
12:12pm, Thursday, 11'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) * AbbVie Inc (NYSE: ABBV) - announced an oncology pa
Grifols starts production of its hyperimmune immunoglobulin as a potential passive immune therapy against COVID-19
08:03am, Thursday, 11'th Jun 2020
Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of therapies with plasma-derived proteins with a track record of more than 100 years dedicated to enhancing people's he
TPG Group Holdings (SBS) Advisors, Inc. Buys Progyny Inc, Allogene Therapeutics Inc, Comcast ...
12:00am, Wednesday, 03'rd Jun 2020TPG Group Holdings (SBS) Advisors, Inc. Buys Progyny Inc, Allogene Therapeutics Inc, Comcast ...
12:00am, Monday, 01'st Jun 2020
A coalition of world-leading medical and research institutions, blood centers, life science companies, technology companies, philanthropic organizations, and COVID-19 survivor groups has come together
